Literature DB >> 16728548

The adrenal gland may be a target of LH action in postmenopausal women.

Maria Alevizaki1, Katerina Saltiki, Emily Mantzou, Eleni Anastasiou, Ilpo Huhtaniemi.   

Abstract

OBJECTIVE: LH receptor expression and function have been demonstrated in the human adrenal cortex, but their involvement in normal adrenal function remains elusive. Because cortisol levels have been reported to be higher in postmenopausal women than in age-matched men, the aim of the present study was to investigate a possible association of adrenal function with the elevated LH levels in postmenopausal women. DESIGN AND METHODS: A group of 112 endocrinologically normal postmenopausal women (mean age 67.6, range 50-88 years) was evaluated. A basal fasting morning sample of peripheral blood was taken for the determination of LH, cortisol, dehydroepiandrosterone-sulphate (DHEA-S), oestradiol (E2), testosterone, sex hormone-binding globulin (SHBG), insulin and glucose. Information about reproductive function, anthropometric parameters and arterial blood pressure was recorded.
RESULTS: The correlation of LH and cortisol was bimodally distributed, with a significant linear correlation up to the LH level of 41 U/l (n = 78, P<0.01), after which the increase of cortisol levelled off. Significant associations were also found between serum DHEA-S and LH levels (P<0.05), as well as between cortisol and testosterone (P<0.0001), but not between E2 and LH. Multivariate analysis showed that the association of cortisol with LH was independent of age and testosterone; the association of DHEA-S with LH was independent of E2, cortisol and age. Significant associations were also found between E2, testosterone and DHEA-S levels (P<0.001).
CONCLUSIONS: These results indicate that adrenal cortisol and DHEA-S production may be stimulated by the highly elevated postmenopausal levels of LH; the physiological significance of this association and plausible contribution to the metabolic syndrome observed after the menopause remain to be evaluated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728548     DOI: 10.1530/eje.1.02165

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  9 in total

1.  Dehydroepiandrosterone sulfate levels reflect endogenous luteinizing hormone production and response to human chorionic gonadotropin challenge in older female macaque (Macaca fascicularis).

Authors:  Francisco M Moran; Jiangang Chen; Nancy A Gee; Pete N Lohstroh; Bill L Lasley
Journal:  Menopause       Date:  2013-03       Impact factor: 2.953

2.  Does the degree of endocrine dyscrasia post-reproduction dictate post-reproductive lifespan? Lessons from semelparous and iteroparous species.

Authors:  Craig S Atwood; Kentaro Hayashi; Sivan Vadakkadath Meethal; Tina Gonzales; Richard L Bowen
Journal:  Geroscience       Date:  2017-03-07       Impact factor: 7.713

Review 3.  Regulation of the adrenocortical stem cell niche: implications for disease.

Authors:  Elisabeth M Walczak; Gary D Hammer
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

4.  Luteinizing hormone correlates with adrenal function in postmenopausal women.

Authors:  Aditi R Saxena; Ellen W Seely
Journal:  Menopause       Date:  2012-11       Impact factor: 2.953

5.  Influence of estradiol and fetal stress on luteinizing hormone, follicle-stimulating hormone, and prolactin in late-gestation fetal sheep.

Authors:  Charles E Wood; Maureen Keller-Wood
Journal:  Neonatology       Date:  2011-03-24       Impact factor: 4.035

6.  Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone.

Authors:  Kathleen M Gavin; Karen L Shea; Ellie Gibbons; Pamela Wolfe; Robert S Schwartz; Margaret E Wierman; Wendy M Kohrt
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-04-06       Impact factor: 4.310

7.  Ovarian and adrenal androgens and their link to high human chorionic gonadotropin levels: a prospective controlled study.

Authors:  René Rodríguez-Gutiérrez; Jesús Zacarías Villarreal-Pérez; Felipe Arturo Morales-Martinez; René Rodríguez-Guajardo; Gloria González-Saldivar; Leonardo G Mancillas-Adame; Neri Alejandro Alvarez-Villalobos; Fernando Javier Lavalle-Gonzalez; José Gerardo González-González
Journal:  Int J Endocrinol       Date:  2014-11-23       Impact factor: 3.257

8.  GnRH antagonist treatment of malignant adrenocortical tumors.

Authors:  Milena Doroszko; Marcin Chrusciel; Joanna Stelmaszewska; Tomasz Slezak; Slawomir Anisimowicz; Ursula Plöckinger; Marcus Quinkler; Marco Bonomi; Slawomir Wolczynski; Ilpo Huhtaniemi; Jorma Toppari; Nafis A Rahman
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

9.  Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome.

Authors:  Luciana Tock; Gláucia Carneiro; Andrea Z Pereira; Sérgio Tufik; Maria Teresa Zanella
Journal:  Int J Endocrinol       Date:  2014-05-07       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.